Hjem › Geografisk atrofi › Washington › Spokane
Kliniske studier for Geografisk atrofi i Spokane, WA
5 studier for Geografisk atrofi søker deltakere på steder i og rundt Spokane (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RekruttererFase 2/3
- Spokane Eye Clinical Research, Spokane
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
RekruttererFase 1/2
- Spokane Eye Clinic, Spokane
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RekruttererFase 3
- Spokane Eye Clinical Research, Spokane
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
RekruttererFase 2
- Spokane Eye Clinical Research;Spokane Eye Surgery Center, Spokane
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
RekruttererFase 1
- Spokane Eye Clinical Research, Spokane
Geografisk atrofi-studier i andre byer
- Dallas, TX8 studier
- Reno, NV8 studier
- Austin, TX7 studier
- Santa Monica, CA7 studier
- Cleveland, OH6 studier
- Houston, TX6 studier
- The Woodlands, TX6 studier
- Naperville, IL6 studier
- Baltimore, MD6 studier
- San Antonio, TX5 studier
- Erie, PA5 studier
- Washington, DC5 studier
Andre studier i Spokane
- Ikke-småcellet lungekreft12 studier
- Brystkreft8 studier
- Eggstokkreft8 studier
- Kolorektal kreft8 studier
- Parkinsons sykdom7 studier
- Prostatakreft6 studier
- Kronisk lymfatisk leukemi6 studier
- Plateepitelcancer i hode og hals6 studier
- Kreft (alle typer)6 studier
- Tripelnegativ brystkreft5 studier
- Melanom5 studier
- Makuladegenerasjon5 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.